Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Larimar Therapeutics Inc (LRMR)

Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Larimar: Q1 Earnings Snapshot

Larimar: Q1 Earnings Snapshot

LRMR : 7.68 (+4.92%)
Larimar: Q4 Earnings Snapshot

Larimar: Q4 Earnings Snapshot

LRMR : 7.68 (+4.92%)
Wall Street Thinks These 2 Biotech Stocks Could Soar in 2024

These two biotech stocks sport notable 12-month price targets. However, they are also uber-risky.

BIIB : 225.23 (-0.05%)
XBI : 91.75 (+2.08%)
XLK : 206.93 (+0.20%)
OCUL : 5.89 (+4.43%)
LRMR : 7.68 (+4.92%)
Larimar: Q3 Earnings Snapshot

Larimar: Q3 Earnings Snapshot

LRMR : 7.68 (+4.92%)
Larimar: Q2 Earnings Snapshot

Larimar: Q2 Earnings Snapshot

LRMR : 7.68 (+4.92%)
Larimar: Q1 Earnings Snapshot

Larimar: Q1 Earnings Snapshot

LRMR : 7.68 (+4.92%)
Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat

Nektar's (NKTR) Q1 loss is narrower than expected while revenues beat estimates.

LLY : 753.02 (-0.62%)
NKTR : 1.7200 (-1.71%)
ITRM : 1.5200 (+4.61%)
LRMR : 7.68 (+4.92%)
Larimar (LRMR) Upgraded to Strong Buy: What Does It Mean for the Stock?

Larimar (LRMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

LRMR : 7.68 (+4.92%)
Theravance's (TBPH) Q1 Earnings and Revenues Miss Estimates

Thervance's (TBPH) first-quarter 2023 loss wider than expected. Revenues decline year over year and also miss estimates.

TBPH : 9.90 (+3.34%)
ITRM : 1.5200 (+4.61%)
LRMR : 7.68 (+4.92%)
VTRS : 11.26 (-0.88%)
New Strong Buy Stocks for May 9th

SBGI, AQST, PLTK, GTX and LRMR have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2023

SBGI : 15.90 (+5.79%)
AQST : 3.23 (-1.22%)
GTX : 9.47 (+1.39%)
LRMR : 7.68 (+4.92%)
PLTK : 8.91 (+1.95%)

Barchart Exclusives

3 Cheapest Dividend Aristocrats To Buy And Hold Forever
Here are three recession-resistant Dividend Aristocrats with attractive valuations and strong dividend growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar